Opportunity Information: Apply for PA 21 180
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) is a National Institutes of Health (NIH) grant opportunity (Funding Opportunity Number PA-21-180) designed to support early-stage, pilot, and preliminary studies that lay the groundwork for larger, full-scale health services research effectiveness trials. The central aim is to help investigators test and refine real-world approaches to improving how substance use disorder (SUD) care is delivered, financed, accessed, and experienced, with a strong emphasis on generating the kind of practical evidence needed before launching more expensive and complex multi-site trials.
The projects this announcement is trying to stimulate focus on health services and economic research related to treatments and services for drug, alcohol, and tobacco use disorders. That includes work that examines how to optimize access to care, improve quality and clinical effectiveness, increase affordability, and ensure appropriate utilization of evidence-based (and potentially evidence-generating) services. A key point is that NIH is not limiting applicants to only brand-new innovations; the FOA also explicitly welcomes studies of common, widely used practices and policies that are already happening in routine care but still lack a solid evidence base. In other words, the opportunity is meant to strengthen decision-making for systems, providers, and policymakers by supporting projects that clarify what works, for whom, in what settings, and at what cost.
Because it uses the R34 mechanism, the emphasis is on preparatory and feasibility-oriented research rather than definitive, fully powered effectiveness trials. Applicants are encouraged to use these funds to assess whether a proposed approach is feasible in the intended setting, acceptable to patients, providers, or organizations, and useful enough to justify scaling up. This can include the kinds of foundational tasks that make later trials viable, such as refining protocols, testing recruitment and retention strategies, verifying data collection methods, examining implementation barriers, piloting outcome measures, and establishing partnerships with clinical sites, community organizations, health systems, or payers. The FOA also highlights the value of understanding practical considerations like workflow fit, staffing needs, and resource constraints, which often determine whether an intervention or policy can be sustained outside of a research context.
The scope of potential studies is broad. Trials and evaluations under this FOA may examine interventions (for example, new care models, care coordination strategies, digital supports, contingency management workflows, medication treatment delivery improvements, or smoking cessation service integrations), practices (such as screening and referral processes, stepped care, telehealth delivery strategies, or workforce training approaches), and policies (including payment models, coverage rules, service authorization requirements, or organizational policies that affect treatment entry and continuity). Importantly, the FOA also recognizes that many people with substance use disorders have comorbid medical and mental health conditions, so studies that address or integrate services for these co-occurring conditions are explicitly within bounds.
This opportunity is categorized as discretionary funding and uses the grant funding instrument. It falls under the Education and Health funding activity category and is associated with CFDA numbers 93.273 and 93.279. The announcement lists an original closing date of 2025-01-07, and it was created on 2021-05-11. While the provided source data does not specify an award ceiling or expected number of awards, the intent of the R34 mechanism generally aligns with supporting smaller, time-limited projects that produce actionable pilot data and a credible plan for subsequent, larger-scale submission.
Eligibility is intentionally wide to encourage participation from many kinds of organizations involved in health and social service delivery. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (including those other than federally recognized tribal governments); public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other entities. The FOA also calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, and even non-U.S. entities (foreign organizations). This wide eligibility signals NIH interest in research that reflects diverse systems of care and community contexts, including underserved and high-need populations.
Finally, the "(Clinical Trial Optional)" designation means applicants may propose a study that includes a clinical trial component if it fits the aims, but they are not required to run a clinical trial to be responsive. In practical terms, that allows applications ranging from pilot randomized or pragmatic trials to other rigorous preliminary study designs focused on services research questions, including economic components such as cost, cost-effectiveness, or budget impact analyses, when relevant. Overall, the FOA is best understood as a launchpad: it funds the early, high-value work needed to demonstrate readiness for a larger effectiveness trial and to reduce uncertainty about whether an approach to SUD treatment and related services can realistically be implemented and evaluated at scale.Apply for PA 21 180
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273, 93.279.
- This funding opportunity was created on 2021-05-11.
- Applicants must submit their applications by 2025-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)
What is this funding opportunity?
This is a National Institutes of Health (NIH) grant opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)." It is associated with Funding Opportunity Number (FON) PA-21-180 and supports early-stage, pilot, and preliminary studies that prepare investigators for larger, full-scale health services research effectiveness trials.
What is the main purpose of this R34 announcement?
The central purpose is to fund feasibility-oriented work that lays the groundwork for later, larger effectiveness trials in real-world settings. The emphasis is on generating practical, decision-relevant evidence about how substance use disorder (SUD) care is delivered, financed, accessed, and experienced, before launching more expensive and complex multi-site studies.
What topics and disorders are in scope?
The scope includes health services and economic research related to treatments and services for drug, alcohol, and tobacco use disorders. Projects may focus on improving access to care, quality, clinical effectiveness, affordability, and appropriate utilization of evidence-based (and evidence-generating) services.
Is this opportunity limited to brand-new innovations?
No. The announcement explicitly welcomes studies of common, widely used practices and policies already occurring in routine care that still lack a strong evidence base. The goal is to clarify what works, for whom, in what settings, and at what cost.
What kinds of studies does the R34 mechanism support?
The R34 mechanism is intended for preparatory and pilot work rather than definitive, fully powered effectiveness trials. Supported studies are typically designed to test feasibility, acceptability, and practical readiness for scaling up into a larger submission.
What are examples of preparatory activities that fit this FOA?
Examples include refining protocols; testing recruitment and retention strategies; verifying data collection methods; examining implementation barriers; piloting outcome measures; and establishing partnerships with clinical sites, community organizations, health systems, or payers. The FOA also highlights evaluating real-world factors like workflow fit, staffing needs, and resource constraints.
What kinds of interventions, practices, or policies can be examined?
The FOA supports a broad range of health services research targets, including interventions, practices, and policies affecting SUD treatment and service delivery. Examples listed include care models, care coordination strategies, digital supports, contingency management workflows, improvements to medication treatment delivery, smoking cessation service integrations, screening and referral processes, stepped care, telehealth delivery strategies, workforce training approaches, payment models, coverage rules, service authorization requirements, and organizational policies that influence treatment entry and continuity.
Can projects include co-occurring medical or mental health conditions?
Yes. The announcement recognizes that many people with SUD have comorbid medical and mental health conditions, and it explicitly includes studies that address or integrate services for co-occurring conditions.
Do applicants have to propose a clinical trial?
No. The FOA is labeled "(Clinical Trial Optional)," meaning a clinical trial component may be included if appropriate, but a clinical trial is not required to be responsive.
If clinical trials are optional, what study designs might still fit?
Based on the description provided, responsive applications can range from pilot randomized or pragmatic trials to other rigorous preliminary study designs focused on health services research questions. Projects may also include economic analyses (such as cost, cost-effectiveness, or budget impact) when relevant.
What is meant by "health services and economic research" in this context?
In this FOA, health services and economic research refers to studying real-world approaches to delivering and financing SUD treatment and related services, including questions about access, utilization, quality, outcomes, and costs. The aim is to produce evidence that helps systems, providers, and policymakers make better-informed decisions.
What is the funding instrument and funding type?
This opportunity uses the grant funding instrument and is categorized as discretionary funding.
Which funding activity category does this opportunity fall under?
It is listed under the Education and Health funding activity category.
What CFDA numbers are associated with this opportunity?
The opportunity is associated with CFDA numbers 93.273 and 93.279.
Who is eligible to apply?
Eligibility is intentionally broad. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (including those other than federally recognized tribal governments); public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other entities.
Are specific institution types and community-based organizations explicitly included?
Yes. The FOA calls out Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, and non-U.S. entities (foreign organizations).
Are foreign organizations allowed to apply?
Yes. The eligibility list explicitly includes non-U.S. entities (foreign organizations).
What is the application deadline shown in the provided information?
The announcement lists an original closing date of 2025-01-07.
When was this funding opportunity created?
The provided information indicates it was created on 2021-05-11.
Does the provided information specify an award ceiling or number of awards?
No. The provided source data does not specify an award ceiling or the expected number of awards.
How should applicants think about the size and intent of an R34 project?
While this summary does not list specific budget or duration limits, it describes the R34 as generally aligned with smaller, time-limited projects that generate actionable pilot data and a credible plan for a subsequent, larger-scale submission.
What kinds of real-world settings or partners are relevant for this FOA?
The FOA emphasizes real-world approaches and encourages building partnerships with clinical sites, community organizations, health systems, and payers, since these relationships can be essential to testing feasibility and planning for larger effectiveness trials.
What outcomes or evidence is this FOA trying to produce before a larger trial?
The FOA emphasizes evidence that reduces uncertainty and demonstrates readiness, such as feasibility and acceptability in the intended setting, workable recruitment and retention approaches, reliable data collection, practical implementation considerations (workflow, staffing, resources), and early signals that an approach is worth scaling to a larger evaluation.
Where does this FOA place emphasis: efficacy in ideal conditions or effectiveness in real-world conditions?
Based on the description provided, the emphasis is on real-world health services research effectiveness questions and practical evidence needed to inform later, larger trials conducted in routine care contexts.
What is the full title and identifier applicants should use to find the announcement?
The title is "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)" and the Funding Opportunity Number is PA-21-180.
Browse more opportunities from the same category: Education, Health
Next opportunity: Cooperative Agreement for CESU-affiliated Partner with Great Lakes-Northern Forest Cooperative Ecosystem Studies Unit
Previous opportunity: Great Lakes Restoration Initiative – Joint Venture Habitat Restoration and Protection
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 21 180
Applicants also applied for:
Applicants who have applied for this opportunity (PA 21 180) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) Apply for RFA DA 22 007 Funding Number: RFA DA 22 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed) Apply for RFA DA 22 005 Funding Number: RFA DA 22 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required) Apply for RFA DA 22 024 Funding Number: RFA DA 22 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R21 - Basic Experimental Studies with Humans Required) Apply for RFA DA 22 030 Funding Number: RFA DA 22 030 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Assessing the Effects of Cannabinoids on HIV-Associated Persistent Inflammation (R01 Clinical Trial Optional) Apply for RFA DA 22 012 Funding Number: RFA DA 22 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) Apply for RFA CA 21 033 Funding Number: RFA CA 21 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 21 034 Funding Number: RFA CA 21 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) Apply for RFA CA 21 035 Funding Number: RFA CA 21 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) Apply for PAR 21 138 Funding Number: PAR 21 138 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Studies to Investigate the Mechanisms of Interrelationship Between Sleep and Substance Use Disorders (R61/R33 Clinical Trials Not Allowed) Apply for RFA DA 22 016 Funding Number: RFA DA 22 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional) Apply for RFA AA 21 009 Funding Number: RFA AA 21 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01 Clinical Trials Optional) Apply for RFA AA 21 007 Funding Number: RFA AA 21 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional) Apply for RFA AA 21 008 Funding Number: RFA AA 21 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) Apply for PAR 21 244 Funding Number: PAR 21 244 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional) Apply for RFA AI 20 069 Funding Number: RFA AI 20 069 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional) Apply for RFA DA 22 017 Funding Number: RFA DA 22 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional) Apply for RFA DA 22 009 Funding Number: RFA DA 22 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Large Scale Mapping and/or Molecular Profiling of Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed) Apply for RFA DA 22 011 Funding Number: RFA DA 22 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed) Apply for RFA DA 22 003 Funding Number: RFA DA 22 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) Apply for RFA CA 21 040 Funding Number: RFA CA 21 040 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 21 180", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.